Welcome to Herreros OncoResearch!

Dr. Alejandro Herreros-Pomares is an emerging researcher in Immuno-Oncology and preclinical cancer models (H-index: 12, 520 WoS citations, 51% in the last 2 years). He currently holds a dual appointment between Universidad Politécnica de Valencia, where he serves as an adjunct professor, and the Instituto de Investigación Sanitaria La Fe (IIS La Fe). At IIS La Fe, he is a beneficiary of an MSCA COFUND fellowship funded by the European Commission and the Spanish Association Against Cancer (AECC), where he is establishing his own research line.

Dr. Herreros-Pomares’ expertise stems from multidisciplinary international collaborations across academia and industry. He has worked in six laboratories in Spain and three abroad, in the US, Belgium, and the Netherlands. Prior to joining IIS La Fe (2024), he was a postdoctoral fellow in the lab of Prof. Dr. Frédéric Amant at KU Leuven. This position was funded first by a Margarita Salas grant and later by an MSCA Postdoctoral Fellowship (2021-2024). Before moving to Belgium, he was awarded a Torres Quevedo postdoctoral grant from the Spanish Ministry of Science and Innovation. In this context, he led the Clinical Genomics and Bioinformatics lab (2019-2021). Dr. Herreros-Pomares obtained his PhD through an FPU fellowship in the molecular oncology lab of Prof. Carlos Camps, after holding a collaboration scholarship from the Spanish Ministry of Education. During his PhD, he received a mobility grant for a six-month internship in the Bioengineering lab of Prof. Lijie Grace Zhang at The George Washington University. He defended his PhD with the International Doctorate mention and received the Extraordinary Doctorate Award (2015-2019).

Dr. Alejandro Herreros-Pomares has participated in 22 national and international research projects. He recently obtained his first project grant as Principal Investigator from Generalitat Valenciana. His research activities have led to 27 publications in peer-reviewed journals, including high-impact journals such as Cell Death Dis, Semin Cancer Biol, Mater Sci Eng C, and Clin Transl Med. He is first author on 11 papers, last author on 2, and corresponding author on 5. Additionally, he has published one review and one book chapter as sole author, and another book chapter as co-first author. He has contributed to 90 national and international conferences, including 2 invited conferences, 22 oral presentations, and 66 posters, and has received 8 awards in Spanish congresses and scientific competitions. Dr. Herreros has been involved in 7 technology-transfer contracts, including 2 as co-PI.